4 results
Approved WMOCompleted
ARA290 is a new drug against neuropathic pain and was succesfully tested in previous studies on patients with neuropathic pain due to diabetes and sarcoidosis. The current study involves sarcoidosis patients with pain due to neuropathy. The purpose…
Approved WMOCompleted
In this study we will assess the effect of ARA290 on nerve damage by taking 4 skin bipsies during treatment.
Approved WMOPending
To compare invasive disease-free survival (iDFS) for ribociclib + ET versus placebo + ET in patients with HR-positive, HER2-negative, EBCwith high risk of recurrence.
Approved WMOCompleted
To assess the analgesic effect of ARA290 in chronic pain patients